Edward M. Kaye M.D., CEO at Stoke Therapeutics, Inc. (STOK), sold 11,150 shares at $6.10 ($68K) on 2024-03-19, disclosed to the SEC on 2024-03-19.
Open-market sale of $68k STOK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |